speb/financial-data huggingface dataset:
PLTR.TO balance_sheet (annual, 2024-12-31) — Allowance For Doubtful Accounts Receivable: -10500000.00
PLTR.TO balance_sheet (quarterly, 2024-12-31) — Allowance For Doubtful Accounts Receivable: -10500000.00
PLTR.TO income_statement (annual, 2024-12-31) — Basic Average Shares: 40847242950.00
PLTR.TO income_statement (annual, 2024-12-31) — Basic EPS: 0.01
PLTR.TO cash_flow (annual, 2024-12-31) — Beginning Cash Position: 850107000.00
PLTR.TO cash_flow (annual, 2024-12-31) — Capital Expenditure: -12634000.00
PLTR.TO balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 239219000.00
PLTR.TO balance_sheet (annual, 2024-12-31) — Capital Stock: 2339000.00
PLTR.TO balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 2098524000.00
PLTR.TO balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 5229987000.00
PLTR.TO cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: 463364000.00
PLTR.TO cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: -340655000.00
PLTR.TO cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: 1153865000.00
PLTR.TO cash_flow (annual, 2024-12-31) — Change In Account Payable: 96793000.00
PLTR.TO cash_flow (annual, 2024-12-31) — Change In Accrued Expense: 115634000.00
PLTR.TO cash_flow (quarterly, 2024-12-31) — Change In Accrued Expense: 73485000.00
PLTR.TO cash_flow (annual, 2024-12-31) — Change In Other Current Assets: 4681000.00
PLTR.TO cash_flow (quarterly, 2024-12-31) — Change In Other Current Assets: 625000.00
PLTR.TO cash_flow (annual, 2024-12-31) — Change In Other Current Liabilities: -44412000.00
PLTR.TO cash_flow (annual, 2024-12-31) — Change In Other Working Capital: 76796000.00
PLTR.TO cash_flow (annual, 2024-12-31) — Change In Payable: 96793000.00
PLTR.TO cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: 96793000.00
PLTR.TO cash_flow (annual, 2024-12-31) — Change In Prepaid Assets: 11883000.00
PLTR.TO cash_flow (annual, 2024-12-31) — Change In Receivables: -211157000.00
PLTR.TO cash_flow (annual, 2024-12-31) — Change In Working Capital: -70097000.00
PLTR.TO cash_flow (annual, 2024-12-31) — Changes In Account Receivables: -211157000.00
PLTR.TO cash_flow (annual, 2024-12-31) — Changes In Cash: 1276574000.00
PLTR.TO balance_sheet (annual, 2024-12-31) — Common Stock: 2339000.00
PLTR.TO balance_sheet (annual, 2024-12-31) — Common Stock Equity: 5003275000.00
PLTR.TO cash_flow (annual, 2024-12-31) — Common Stock Payments: -64196000.00
PLTR.TO cash_flow (quarterly, 2024-12-31) — Common Stock Payments: -18598000.00
PLTR.TO balance_sheet (annual, 2024-12-31) — Construction In Progress: 7632000.00
PLTR.TO balance_sheet (quarterly, 2024-12-31) — Construction In Progress: 7632000.00
PLTR.TO income_statement (annual, 2024-12-31) — Cost Of Revenue: 565990000.00
PLTR.TO balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 427046000.00
PLTR.TO balance_sheet (annual, 2024-12-31) — Current Assets: 5934289000.00
PLTR.TO balance_sheet (annual, 2024-12-31) — Current Capital Lease Obligation: 43993000.00
PLTR.TO balance_sheet (quarterly, 2024-12-31) — Current Capital Lease Obligation: 43993000.00
PLTR.TO balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 43993000.00
PLTR.TO balance_sheet (quarterly, 2024-12-31) — Current Debt And Capital Lease Obligation: 43993000.00
PLTR.TO balance_sheet (annual, 2024-12-31) — Current Deferred Liabilities: 524876000.00
PLTR.TO balance_sheet (annual, 2024-12-31) — Current Deferred Revenue: 524876000.00
PLTR.TO balance_sheet (annual, 2024-12-31) — Current Liabilities: 996018000.00
PLTR.TO cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 31587000.00
PLTR.TO cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 31587000.00
PLTR.TO income_statement (annual, 2024-12-31) — Diluted Average Shares: 44489736212.00
PLTR.TO income_statement (annual, 2024-12-31) — Diluted EPS: 0.01
PLTR.TO income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: 462190000.00
PLTR.TO income_statement (annual, 2024-12-31) — EBIT: 310403000.00
PLTR.TO income_statement (annual, 2024-12-31) — EBITDA: 341990000.00
PLTR.TO cash_flow (annual, 2024-12-31) — Effect Of Exchange Rate Changes: -6745000.00
PLTR.TO cash_flow (annual, 2024-12-31) — End Cash Position: 2119936000.00
PLTR.TO cash_flow (annual, 2024-12-31) — Financing Cash Flow: 463364000.00
PLTR.TO cash_flow (annual, 2024-12-31) — Free Cash Flow: 1141231000.00
PLTR.TO balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: -5611000.00
PLTR.TO income_statement (annual, 2024-12-31) — General And Administrative Expense: 593481000.00
PLTR.TO balance_sheet (annual, 2024-12-31) — Gross Accounts Receivable: 585548000.00
PLTR.TO balance_sheet (quarterly, 2024-12-31) — Gross Accounts Receivable: 585548000.00
PLTR.TO balance_sheet (annual, 2024-12-31) — Gross PPE: 363377000.00
PLTR.TO income_statement (annual, 2024-12-31) — Gross Profit: 2299517000.00
PLTR.TO cash_flow (annual, 2024-12-31) — Income Tax Paid Supplemental Data: 16179000.00
PLTR.TO income_statement (annual, 2024-12-31) — Interest Income: 196792000.00
PLTR.TO income_statement (annual, 2024-12-31) — Interest Income Non Operating: 196792000.00
PLTR.TO balance_sheet (annual, 2024-12-31) — Invested Capital: 5003275000.00
PLTR.TO cash_flow (annual, 2024-12-31) — Investing Cash Flow: -340655000.00
PLTR.TO balance_sheet (annual, 2024-12-31) — Leases: 85284000.00
PLTR.TO balance_sheet (quarterly, 2024-12-31) — Leases: 85284000.00
PLTR.TO balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 195226000.00
PLTR.TO balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 195226000.00
PLTR.TO balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 69721000.00
PLTR.TO balance_sheet (quarterly, 2024-12-31) — Machinery Furniture Equipment: 69721000.00
PLTR.TO balance_sheet (annual, 2024-12-31) — Minority Interest: 91132000.00
PLTR.TO income_statement (annual, 2024-12-31) — Minority Interests: -5728000.00
PLTR.TO cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: -64196000.00
PLTR.TO cash_flow (quarterly, 2024-12-31) — Net Common Stock Issuance: -18598000.00
PLTR.TO income_statement (annual, 2024-12-31) — Net Income: 462190000.00
PLTR.TO income_statement (annual, 2024-12-31) — Net Income Common Stockholders: 462190000.00
PLTR.TO income_statement (annual, 2024-12-31) — Net Income Continuous Operations: 467918000.00
PLTR.TO income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 462190000.00
PLTR.TO income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 462190000.00
PLTR.TO cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: 467918000.00
PLTR.TO income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: 467918000.00
PLTR.TO income_statement (annual, 2024-12-31) — Net Interest Income: 196792000.00
PLTR.TO cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: -328021000.00
PLTR.TO income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: 196792000.00
PLTR.TO cash_flow (annual, 2024-12-31) — Net Other Financing Charges: -217836000.00
PLTR.TO cash_flow (annual, 2024-12-31) — Net Other Investing Changes: -5615000.00
PLTR.TO cash_flow (quarterly, 2024-12-31) — Net Other Investing Changes: -1615000.00
PLTR.TO balance_sheet (annual, 2024-12-31) — Net PPE: 240378000.00
PLTR.TO cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -12634000.00
PLTR.TO balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 5003275000.00
PLTR.TO balance_sheet (annual, 2024-12-31) — Non Current Deferred Liabilities: 41548000.00
PLTR.TO balance_sheet (annual, 2024-12-31) — Non Current Deferred Revenue: 41548000.00
PLTR.TO income_statement (annual, 2024-12-31) — Normalized EBITDA: 341990000.00
PLTR.TO income_statement (annual, 2024-12-31) — Normalized Income: 462190000.00
PLTR.TO cash_flow (annual, 2024-12-31) — Operating Cash Flow: 1153865000.00
PLTR.TO income_statement (annual, 2024-12-31) — Operating Income: 310403000.00
PLTR.TO income_statement (annual, 2024-12-31) — Operating Revenue: 2865507000.00
PLTR.TO balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 2338795190.00
PLTR.TO balance_sheet (annual, 2024-12-31) — Other Current Assets: 129254000.00
PLTR.TO balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: -5611000.00
PLTR.TO income_statement (annual, 2024-12-31) — Other Gand A: 593481000.00
PLTR.TO income_statement (annual, 2024-12-31) — Other Income Expense: -18022000.00
PLTR.TO cash_flow (annual, 2024-12-31) — Other Non Cash Items: 13513000.00
PLTR.TO balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 166217000.00
PLTR.TO balance_sheet (annual, 2024-12-31) — Other Non Current Liabilities: 13685000.00
PLTR.TO income_statement (annual, 2024-12-31) — Other Non Operating Income Expenses: -18022000.00
PLTR.TO balance_sheet (annual, 2024-12-31) — Other Properties: 200740000.00
PLTR.TO balance_sheet (annual, 2024-12-31) — Other Short Term Investments: 3131463000.00
PLTR.TO balance_sheet (annual, 2024-12-31) — Payables: 103000.00
PLTR.TO balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 427149000.00
PLTR.TO income_statement (annual, 2024-12-31) — Pretax Income: 489173000.00
PLTR.TO cash_flow (annual, 2024-12-31) — Proceeds From Stock Option Exercised: 745396000.00
PLTR.TO balance_sheet (annual, 2024-12-31) — Properties: 0.00
PLTR.TO balance_sheet (quarterly, 2024-12-31) — Properties: 0.00
PLTR.TO cash_flow (annual, 2024-12-31) — Purchase Of Investment: -5401528000.00
PLTR.TO cash_flow (annual, 2024-12-31) — Purchase Of PPE: -12634000.00
PLTR.TO balance_sheet (annual, 2024-12-31) — Receivables: 575048000.00
PLTR.TO income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 565990000.00
PLTR.TO income_statement (annual, 2024-12-31) — Reconciled Depreciation: 31587000.00
PLTR.TO cash_flow (annual, 2024-12-31) — Repurchase Of Capital Stock: -64196000.00
PLTR.TO cash_flow (quarterly, 2024-12-31) — Repurchase Of Capital Stock: -18598000.00
PLTR.TO income_statement (annual, 2024-12-31) — Research And Development: 507878000.00
PLTR.TO balance_sheet (annual, 2024-12-31) — Retained Earnings: -5187423000.00
PLTR.TO cash_flow (annual, 2024-12-31) — Sale Of Investment: 5073507000.00
PLTR.TO income_statement (annual, 2024-12-31) — Selling And Marketing Expense: 887755000.00
PLTR.TO income_statement (annual, 2024-12-31) — Selling General And Administration: 1481236000.00
PLTR.TO balance_sheet (annual, 2024-12-31) — Share Issued: 2338795190.00
PLTR.TO cash_flow (annual, 2024-12-31) — Stock Based Compensation: 691638000.00
PLTR.TO balance_sheet (annual, 2024-12-31) — Stockholders Equity: 5003275000.00
PLTR.TO balance_sheet (annual, 2024-12-31) — Tangible Book Value: 5003275000.00
PLTR.TO income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
PLTR.TO income_statement (annual, 2024-12-31) — Tax Provision: 21255000.00
PLTR.TO income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.04
PLTR.TO balance_sheet (annual, 2024-12-31) — Total Assets: 6340884000.00
PLTR.TO balance_sheet (annual, 2024-12-31) — Total Capitalization: 5003275000.00
PLTR.TO balance_sheet (annual, 2024-12-31) — Total Debt: 239219000.00
PLTR.TO balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 5094407000.00
PLTR.TO income_statement (annual, 2024-12-31) — Total Expenses: 2555104000.00
PLTR.TO balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 1246477000.00
PLTR.TO balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 406595000.00
PLTR.TO balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 250459000.00
PLTR.TO income_statement (annual, 2024-12-31) — Total Operating Income As Reported: 310403000.00
PLTR.TO balance_sheet (annual, 2024-12-31) — Total Tax Payable: 42243000.00
PLTR.TO balance_sheet (quarterly, 2024-12-31) — Total Tax Payable: 42243000.00
PLTR.TO cash_flow (annual, 2024-12-31) — Unrealized Gain Loss On Investment Securities: 19306000.00
PLTR.TO cash_flow (quarterly, 2024-12-31) — Unrealized Gain Loss On Investment Securities: -6715000.00
PLTR.TO balance_sheet (annual, 2024-12-31) — Working Capital: 4938271000.00
PLTR.TO income_statement (quarterly, 2025-03-31) — +Operating Expense: 534837000.00
PLTR.TO income_statement (quarterly, 2025-03-31) — +Total Revenue: 883855000.00
PLTR.TO balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 2330000.00
PLTR.TO balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 725205000.00
PLTR.TO balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -129669000.00
PLTR.TO balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 10398181000.00
PLTR.TO income_statement (quarterly, 2025-03-31) — Basic Average Shares: 42635605390.00
PLTR.TO income_statement (quarterly, 2025-03-31) — Basic EPS: 0.00
PLTR.TO cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 2119936000.00
PLTR.TO cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -6184000.00
PLTR.TO balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 244596000.00
PLTR.TO balance_sheet (quarterly, 2025-03-31) — Capital Stock: 2360000.00
PLTR.TO balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 993464000.00
PLTR.TO balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 5430689000.00
PLTR.TO cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: -28897000.00
PLTR.TO cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -1390277000.00
PLTR.TO cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: 310263000.00
PLTR.TO cash_flow (quarterly, 2025-03-31) — Change In Account Payable: 22395000.00
PLTR.TO cash_flow (quarterly, 2025-03-31) — Change In Other Current Liabilities: -13247000.00
PLTR.TO cash_flow (quarterly, 2025-03-31) — Change In Other Working Capital: 18760000.00
PLTR.TO cash_flow (quarterly, 2025-03-31) — Change In Payable: 22395000.00
PLTR.TO cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: 22395000.00
PLTR.TO cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: 40730000.00
PLTR.TO cash_flow (quarterly, 2025-03-31) — Change In Receivables: -134959000.00
PLTR.TO cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -66321000.00
PLTR.TO cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: -134959000.00
PLTR.TO cash_flow (quarterly, 2025-03-31) — Changes In Cash: -1108911000.00
PLTR.TO balance_sheet (quarterly, 2025-03-31) — Common Stock: 2360000.00
PLTR.TO balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 5424155000.00
PLTR.TO cash_flow (quarterly, 2025-03-31) — Common Stock Payments: -17998000.00
PLTR.TO balance_sheet (quarterly, 2025-03-31) — Construction In Progress: 7261000.00
PLTR.TO income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 172970000.00
PLTR.TO balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 371061000.00
PLTR.TO balance_sheet (quarterly, 2025-03-31) — Current Assets: 6282599000.00
PLTR.TO balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 44419000.00
PLTR.TO balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 44419000.00
PLTR.TO balance_sheet (quarterly, 2025-03-31) — Current Deferred Liabilities: 549633000.00
PLTR.TO balance_sheet (quarterly, 2025-03-31) — Current Deferred Revenue: 549633000.00
PLTR.TO balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 967443000.00
PLTR.TO cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 6622000.00
PLTR.TO cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 6622000.00
PLTR.TO income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 46341343753.00
PLTR.TO income_statement (quarterly, 2025-03-31) — Diluted EPS: 0.00
PLTR.TO income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 214031000.00
PLTR.TO income_statement (quarterly, 2025-03-31) — EBIT: 176048000.00
PLTR.TO income_statement (quarterly, 2025-03-31) — EBITDA: 182670000.00
PLTR.TO cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: 3980000.00
PLTR.TO cash_flow (quarterly, 2025-03-31) — End Cash Position: 1015005000.00
PLTR.TO cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -28897000.00
PLTR.TO cash_flow (quarterly, 2025-03-31) — Free Cash Flow: 304079000.00
PLTR.TO balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: -2994000.00
PLTR.TO income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 163639000.00
PLTR.TO balance_sheet (quarterly, 2025-03-31) — Gross PPE: 378686000.00
PLTR.TO income_statement (quarterly, 2025-03-31) — Gross Profit: 710885000.00
PLTR.TO income_statement (quarterly, 2025-03-31) — Interest Income: 50441000.00
PLTR.TO income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 50441000.00
PLTR.TO balance_sheet (quarterly, 2025-03-31) — Invested Capital: 5424155000.00
PLTR.TO cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -1390277000.00
PLTR.TO balance_sheet (quarterly, 2025-03-31) — Leases: 89216000.00
PLTR.TO balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 200177000.00
PLTR.TO balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 200177000.00
PLTR.TO balance_sheet (quarterly, 2025-03-31) — Machinery Furniture Equipment: 72861000.00
PLTR.TO balance_sheet (quarterly, 2025-03-31) — Minority Interest: 94818000.00
PLTR.TO income_statement (quarterly, 2025-03-31) — Minority Interests: -3686000.00
PLTR.TO cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: -17998000.00
PLTR.TO income_statement (quarterly, 2025-03-31) — Net Income: 214031000.00
PLTR.TO income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 214031000.00
PLTR.TO income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 217717000.00
PLTR.TO income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 214031000.00
PLTR.TO income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 214031000.00
PLTR.TO cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: 217717000.00
PLTR.TO income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 217717000.00
PLTR.TO income_statement (quarterly, 2025-03-31) — Net Interest Income: 50441000.00
PLTR.TO cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: -1354093000.00
PLTR.TO income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: 50441000.00
PLTR.TO cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: -95481000.00
PLTR.TO cash_flow (quarterly, 2025-03-31) — Net Other Investing Changes: -30000000.00
PLTR.TO balance_sheet (quarterly, 2025-03-31) — Net PPE: 249017000.00
PLTR.TO cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -6184000.00
PLTR.TO balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 5424155000.00
PLTR.TO balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Liabilities: 37835000.00
PLTR.TO balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Revenue: 37835000.00
PLTR.TO income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 182670000.00
PLTR.TO income_statement (quarterly, 2025-03-31) — Normalized Income: 214031000.00
PLTR.TO cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: 310263000.00
PLTR.TO income_statement (quarterly, 2025-03-31) — Operating Income: 176048000.00
PLTR.TO income_statement (quarterly, 2025-03-31) — Operating Revenue: 883855000.00
PLTR.TO balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 2359663165.00
PLTR.TO balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 126705000.00
PLTR.TO balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: -2994000.00
PLTR.TO income_statement (quarterly, 2025-03-31) — Other Gand A: 163639000.00
PLTR.TO income_statement (quarterly, 2025-03-31) — Other Income Expense: -3173000.00
PLTR.TO cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: -3094000.00
PLTR.TO balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 205301000.00
PLTR.TO balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 12489000.00
PLTR.TO income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: -3173000.00
PLTR.TO balance_sheet (quarterly, 2025-03-31) — Other Properties: 209348000.00
PLTR.TO balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 4437225000.00
PLTR.TO balance_sheet (quarterly, 2025-03-31) — Payables: 2330000.00
PLTR.TO balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 373391000.00
PLTR.TO income_statement (quarterly, 2025-03-31) — Pretax Income: 223316000.00
PLTR.TO cash_flow (quarterly, 2025-03-31) — Proceeds From Stock Option Exercised: 66584000.00
PLTR.TO balance_sheet (quarterly, 2025-03-31) — Properties: 0.00
PLTR.TO cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: -1704720000.00
PLTR.TO cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -6184000.00
PLTR.TO balance_sheet (quarterly, 2025-03-31) — Receivables: 725205000.00
PLTR.TO income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 172970000.00
PLTR.TO income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 6622000.00
PLTR.TO cash_flow (quarterly, 2025-03-31) — Repurchase Of Capital Stock: -17998000.00
PLTR.TO income_statement (quarterly, 2025-03-31) — Research And Development: 134889000.00
PLTR.TO balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -4973392000.00
PLTR.TO cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 350627000.00
PLTR.TO income_statement (quarterly, 2025-03-31) — Selling And Marketing Expense: 236309000.00
PLTR.TO income_statement (quarterly, 2025-03-31) — Selling General And Administration: 399948000.00
PLTR.TO balance_sheet (quarterly, 2025-03-31) — Share Issued: 2359663165.00
PLTR.TO cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 155339000.00
PLTR.TO balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 5424155000.00
PLTR.TO balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 5424155000.00
PLTR.TO income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
PLTR.TO income_statement (quarterly, 2025-03-31) — Tax Provision: 5599000.00
PLTR.TO income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.03
PLTR.TO balance_sheet (quarterly, 2025-03-31) — Total Assets: 6736917000.00
PLTR.TO balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 5424155000.00
PLTR.TO balance_sheet (quarterly, 2025-03-31) — Total Debt: 244596000.00
PLTR.TO balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 5518973000.00
PLTR.TO income_statement (quarterly, 2025-03-31) — Total Expenses: 707807000.00
PLTR.TO balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 1217944000.00
PLTR.TO balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 454318000.00
PLTR.TO balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 250501000.00
PLTR.TO income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: 176048000.00
PLTR.TO cash_flow (quarterly, 2025-03-31) — Unrealized Gain Loss On Investment Securities: 10688000.00
PLTR.TO balance_sheet (quarterly, 2025-03-31) — Working Capital: 5315156000.00
PLTR.TO income_statement (quarterly, 2025-06-30) — +Operating Expense: 541446000.00
PLTR.TO income_statement (quarterly, 2025-06-30) — +Total Revenue: 1003697000.00
PLTR.TO balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 10774000.00
PLTR.TO balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 747484000.00
PLTR.TO balance_sheet (quarterly, 2025-06-30) — Accumulated Depreciation: -138176000.00
PLTR.TO balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 10568473000.00
PLTR.TO income_statement (quarterly, 2025-06-30) — Basic Average Shares: 42935438739.00
PLTR.TO income_statement (quarterly, 2025-06-30) — Basic EPS: 0.01
PLTR.TO cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 1015005000.00
PLTR.TO cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -7634000.00
PLTR.TO balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 237812000.00
PLTR.TO balance_sheet (quarterly, 2025-06-30) — Capital Stock: 2372000.00
PLTR.TO balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 929547000.00
PLTR.TO balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 6000422000.00
PLTR.TO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: 6450000.00
PLTR.TO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -617010000.00
PLTR.TO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 539251000.00
PLTR.TO cash_flow (quarterly, 2025-06-30) — Change In Account Payable: 25807000.00
PLTR.TO cash_flow (quarterly, 2025-06-30) — Change In Other Current Liabilities: -11690000.00
PLTR.TO cash_flow (quarterly, 2025-06-30) — Change In Other Working Capital: 101906000.00
PLTR.TO cash_flow (quarterly, 2025-06-30) — Change In Payable: 25807000.00
PLTR.TO cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: 25807000.00
PLTR.TO cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: -48037000.00
PLTR.TO cash_flow (quarterly, 2025-06-30) — Change In Receivables: -28542000.00
PLTR.TO cash_flow (quarterly, 2025-06-30) — Change In Working Capital: 39444000.00
PLTR.TO cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: -28542000.00
PLTR.TO cash_flow (quarterly, 2025-06-30) — Changes In Cash: -71309000.00
PLTR.TO balance_sheet (quarterly, 2025-06-30) — Common Stock: 2372000.00
PLTR.TO balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 5928901000.00
PLTR.TO cash_flow (quarterly, 2025-06-30) — Common Stock Payments: -18596000.00
PLTR.TO balance_sheet (quarterly, 2025-06-30) — Construction In Progress: 6533000.00
PLTR.TO income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 192934000.00
PLTR.TO balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 393623000.00
PLTR.TO balance_sheet (quarterly, 2025-06-30) — Current Assets: 6890393000.00
PLTR.TO balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 45465000.00
PLTR.TO balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 45465000.00
PLTR.TO balance_sheet (quarterly, 2025-06-30) — Current Deferred Liabilities: 639778000.00
PLTR.TO balance_sheet (quarterly, 2025-06-30) — Current Deferred Revenue: 639778000.00
PLTR.TO balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 1089640000.00
PLTR.TO cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 6530000.00
PLTR.TO cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 6530000.00
PLTR.TO income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 46524580281.00
PLTR.TO income_statement (quarterly, 2025-06-30) — Diluted EPS: 0.01
PLTR.TO income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 326727000.00
PLTR.TO income_statement (quarterly, 2025-06-30) — EBIT: 269317000.00
PLTR.TO income_statement (quarterly, 2025-06-30) — EBITDA: 275847000.00
PLTR.TO cash_flow (quarterly, 2025-06-30) — Effect Of Exchange Rate Changes: 7538000.00
PLTR.TO cash_flow (quarterly, 2025-06-30) — End Cash Position: 951234000.00
PLTR.TO cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: 6450000.00
PLTR.TO cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 531617000.00
PLTR.TO balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: 4721000.00
PLTR.TO income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 162615000.00
PLTR.TO balance_sheet (quarterly, 2025-06-30) — Gross PPE: 385173000.00
PLTR.TO income_statement (quarterly, 2025-06-30) — Gross Profit: 810763000.00
PLTR.TO income_statement (quarterly, 2025-06-30) — Interest Income: 56255000.00
PLTR.TO income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: 56255000.00
PLTR.TO balance_sheet (quarterly, 2025-06-30) — Invested Capital: 5928901000.00
PLTR.TO cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -617010000.00
PLTR.TO balance_sheet (quarterly, 2025-06-30) — Leases: 92401000.00
PLTR.TO balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 192347000.00
PLTR.TO balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 192347000.00
PLTR.TO balance_sheet (quarterly, 2025-06-30) — Machinery Furniture Equipment: 82765000.00
PLTR.TO balance_sheet (quarterly, 2025-06-30) — Minority Interest: 96663000.00
PLTR.TO income_statement (quarterly, 2025-06-30) — Minority Interests: -1845000.00
PLTR.TO cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: -18596000.00
PLTR.TO income_statement (quarterly, 2025-06-30) — Net Income: 326727000.00
PLTR.TO income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 326727000.00
PLTR.TO income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 328572000.00
PLTR.TO income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 326727000.00
PLTR.TO income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 326727000.00
PLTR.TO cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: 328572000.00
PLTR.TO income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 328572000.00
PLTR.TO income_statement (quarterly, 2025-06-30) — Net Interest Income: 56255000.00
PLTR.TO cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: -639376000.00
PLTR.TO income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: 56255000.00
PLTR.TO cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: 14427000.00
PLTR.TO balance_sheet (quarterly, 2025-06-30) — Net PPE: 246997000.00
PLTR.TO cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -7634000.00
PLTR.TO balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 5928901000.00
PLTR.TO balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Liabilities: 46129000.00
PLTR.TO balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Revenue: 46129000.00
PLTR.TO income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 275847000.00
PLTR.TO income_statement (quarterly, 2025-06-30) — Normalized Income: 326727000.00
PLTR.TO cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 539251000.00
PLTR.TO income_statement (quarterly, 2025-06-30) — Operating Income: 269317000.00
PLTR.TO income_statement (quarterly, 2025-06-30) — Operating Revenue: 1003697000.00
PLTR.TO balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 2371847000.00
PLTR.TO balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 142487000.00
PLTR.TO balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: 4721000.00
PLTR.TO income_statement (quarterly, 2025-06-30) — Other Gand A: 162615000.00
PLTR.TO income_statement (quarterly, 2025-06-30) — Other Income Expense: 6596000.00
PLTR.TO cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 5186000.00
PLTR.TO balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 228298000.00
PLTR.TO balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 12008000.00
PLTR.TO income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 6596000.00
PLTR.TO balance_sheet (quarterly, 2025-06-30) — Other Properties: 203474000.00
PLTR.TO balance_sheet (quarterly, 2025-06-30) — Other Short Term Investments: 5070875000.00
PLTR.TO balance_sheet (quarterly, 2025-06-30) — Payables: 10774000.00
PLTR.TO balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 404397000.00
PLTR.TO income_statement (quarterly, 2025-06-30) — Pretax Income: 332168000.00
PLTR.TO cash_flow (quarterly, 2025-06-30) — Proceeds From Stock Option Exercised: 28617000.00
PLTR.TO balance_sheet (quarterly, 2025-06-30) — Properties: 0.00
PLTR.TO cash_flow (quarterly, 2025-06-30) — Purchase Of Investment: -941511000.00
PLTR.TO cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -7634000.00
PLTR.TO balance_sheet (quarterly, 2025-06-30) — Receivables: 747484000.00
PLTR.TO income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 192934000.00
PLTR.TO income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 6530000.00
PLTR.TO cash_flow (quarterly, 2025-06-30) — Repurchase Of Capital Stock: -18596000.00
PLTR.TO income_statement (quarterly, 2025-06-30) — Research And Development: 135043000.00
PLTR.TO balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -4646665000.00
PLTR.TO cash_flow (quarterly, 2025-06-30) — Sale Of Investment: 302135000.00
PLTR.TO income_statement (quarterly, 2025-06-30) — Selling And Marketing Expense: 243788000.00
PLTR.TO income_statement (quarterly, 2025-06-30) — Selling General And Administration: 406403000.00
PLTR.TO balance_sheet (quarterly, 2025-06-30) — Share Issued: 2371847000.00
PLTR.TO cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 159971000.00
PLTR.TO balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 5928901000.00
PLTR.TO balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 5928901000.00
PLTR.TO income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
PLTR.TO income_statement (quarterly, 2025-06-30) — Tax Provision: 3596000.00
PLTR.TO income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.01
PLTR.TO balance_sheet (quarterly, 2025-06-30) — Total Assets: 7365688000.00
PLTR.TO balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 5928901000.00
PLTR.TO balance_sheet (quarterly, 2025-06-30) — Total Debt: 237812000.00
PLTR.TO balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 6025564000.00
PLTR.TO income_statement (quarterly, 2025-06-30) — Total Expenses: 734380000.00
PLTR.TO balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 1340124000.00
PLTR.TO balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 475295000.00
PLTR.TO balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 250484000.00
PLTR.TO income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: 269317000.00
PLTR.TO cash_flow (quarterly, 2025-06-30) — Unrealized Gain Loss On Investment Securities: -11140000.00
PLTR.TO balance_sheet (quarterly, 2025-06-30) — Working Capital: 5800753000.00
PLTR.TO income_statement (quarterly, 2025-09-30) — +Operating Expense: 580529000.00
PLTR.TO income_statement (quarterly, 2025-09-30) — +Total Revenue: 1181092000.00
PLTR.TO balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 67503000.00
PLTR.TO balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 1005910000.00
PLTR.TO balance_sheet (quarterly, 2025-09-30) — Accumulated Depreciation: -142790000.00
PLTR.TO balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 10747603000.00
PLTR.TO income_statement (quarterly, 2025-09-30) — Basic Average Shares: 43152748488.00
PLTR.TO income_statement (quarterly, 2025-09-30) — Basic EPS: 0.01
PLTR.TO cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 951234000.00
PLTR.TO cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -6792000.00
PLTR.TO balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 235436000.00
PLTR.TO balance_sheet (quarterly, 2025-09-30) — Capital Stock: 2383000.00
PLTR.TO balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 1615967000.00
PLTR.TO balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 6437817000.00
PLTR.TO cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: 6435000.00
PLTR.TO cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: 181567000.00
PLTR.TO cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: 507664000.00
PLTR.TO cash_flow (quarterly, 2025-09-30) — Change In Account Payable: 42380000.00
PLTR.TO cash_flow (quarterly, 2025-09-30) — Change In Other Current Liabilities: -14564000.00
PLTR.TO cash_flow (quarterly, 2025-09-30) — Change In Other Working Capital: 39488000.00
PLTR.TO cash_flow (quarterly, 2025-09-30) — Change In Payable: 42380000.00
PLTR.TO cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 42380000.00
PLTR.TO cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: 57650000.00
PLTR.TO cash_flow (quarterly, 2025-09-30) — Change In Receivables: -259476000.00
PLTR.TO cash_flow (quarterly, 2025-09-30) — Change In Working Capital: -134522000.00
PLTR.TO cash_flow (quarterly, 2025-09-30) — Changes In Account Receivables: -259476000.00
PLTR.TO cash_flow (quarterly, 2025-09-30) — Changes In Cash: 695666000.00
PLTR.TO balance_sheet (quarterly, 2025-09-30) — Common Stock: 2383000.00
PLTR.TO balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 6590457000.00
PLTR.TO cash_flow (quarterly, 2025-09-30) — Common Stock Payments: -19195000.00
PLTR.TO balance_sheet (quarterly, 2025-09-30) — Construction In Progress: 5959000.00
PLTR.TO income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 207307000.00
PLTR.TO balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 381737000.00
PLTR.TO balance_sheet (quarterly, 2025-09-30) — Current Assets: 7586156000.00
PLTR.TO balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 46271000.00
PLTR.TO balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 46271000.00
PLTR.TO balance_sheet (quarterly, 2025-09-30) — Current Deferred Liabilities: 684892000.00
PLTR.TO balance_sheet (quarterly, 2025-09-30) — Current Deferred Revenue: 684892000.00
PLTR.TO balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 1180403000.00
PLTR.TO cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 5975000.00
PLTR.TO cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 5975000.00
PLTR.TO income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 46672436589.00
PLTR.TO income_statement (quarterly, 2025-09-30) — Diluted EPS: 0.01
PLTR.TO income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 475599000.00
PLTR.TO income_statement (quarterly, 2025-09-30) — EBIT: 393256000.00
PLTR.TO income_statement (quarterly, 2025-09-30) — EBITDA: 399231000.00
PLTR.TO cash_flow (quarterly, 2025-09-30) — Effect Of Exchange Rate Changes: -2074000.00
PLTR.TO cash_flow (quarterly, 2025-09-30) — End Cash Position: 1644826000.00
PLTR.TO cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: 6435000.00
PLTR.TO cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 500872000.00
PLTR.TO balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: 11537000.00
PLTR.TO income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 161702000.00
PLTR.TO balance_sheet (quarterly, 2025-09-30) — Gross PPE: 392811000.00
PLTR.TO income_statement (quarterly, 2025-09-30) — Gross Profit: 973785000.00
PLTR.TO income_statement (quarterly, 2025-09-30) — Interest Income: 59762000.00
PLTR.TO income_statement (quarterly, 2025-09-30) — Interest Income Non Operating: 59762000.00
PLTR.TO balance_sheet (quarterly, 2025-09-30) — Invested Capital: 6590457000.00
PLTR.TO cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: 181567000.00
PLTR.TO balance_sheet (quarterly, 2025-09-30) — Leases: 97182000.00
PLTR.TO balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 189165000.00
PLTR.TO balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 189165000.00
PLTR.TO balance_sheet (quarterly, 2025-09-30) — Machinery Furniture Equipment: 85355000.00
PLTR.TO balance_sheet (quarterly, 2025-09-30) — Minority Interest: 97812000.00
PLTR.TO income_statement (quarterly, 2025-09-30) — Minority Interests: -1149000.00
PLTR.TO cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: -19195000.00
PLTR.TO income_statement (quarterly, 2025-09-30) — Net Income: 475599000.00
PLTR.TO income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 475599000.00
PLTR.TO income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 476748000.00
PLTR.TO income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 475599000.00
PLTR.TO income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 475599000.00
PLTR.TO cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: 476748000.00
PLTR.TO income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 476748000.00
PLTR.TO income_statement (quarterly, 2025-09-30) — Net Interest Income: 59762000.00
PLTR.TO cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: 189359000.00
PLTR.TO income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: 59762000.00
PLTR.TO cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: -8000.00
PLTR.TO balance_sheet (quarterly, 2025-09-30) — Net PPE: 250021000.00
PLTR.TO cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -6792000.00
PLTR.TO balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 6590457000.00
PLTR.TO balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Liabilities: 45471000.00
PLTR.TO balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Revenue: 45471000.00
PLTR.TO income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 399231000.00
PLTR.TO income_statement (quarterly, 2025-09-30) — Normalized Income: 475599000.00
PLTR.TO cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 507664000.00
PLTR.TO income_statement (quarterly, 2025-09-30) — Operating Income: 393256000.00
PLTR.TO income_statement (quarterly, 2025-09-30) — Operating Revenue: 1181092000.00
PLTR.TO balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 2383314028.00
PLTR.TO balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 142429000.00
PLTR.TO balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: 11537000.00
PLTR.TO income_statement (quarterly, 2025-09-30) — Other Gand A: 161702000.00
PLTR.TO income_statement (quarterly, 2025-09-30) — Other Income Expense: 27483000.00
PLTR.TO cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: -18312000.00
PLTR.TO balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 277783000.00
PLTR.TO balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 10652000.00
PLTR.TO income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 27483000.00
PLTR.TO balance_sheet (quarterly, 2025-09-30) — Other Properties: 204315000.00
PLTR.TO balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 4821850000.00
PLTR.TO balance_sheet (quarterly, 2025-09-30) — Payables: 67503000.00
PLTR.TO balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 449240000.00
PLTR.TO income_statement (quarterly, 2025-09-30) — Pretax Income: 480501000.00
PLTR.TO cash_flow (quarterly, 2025-09-30) — Proceeds From Stock Option Exercised: 25638000.00
PLTR.TO balance_sheet (quarterly, 2025-09-30) — Properties: 0.00
PLTR.TO cash_flow (quarterly, 2025-09-30) — Purchase Of Investment: -3518206000.00
PLTR.TO cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -6792000.00
PLTR.TO balance_sheet (quarterly, 2025-09-30) — Receivables: 1005910000.00
PLTR.TO income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 207307000.00
PLTR.TO income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 5975000.00
PLTR.TO cash_flow (quarterly, 2025-09-30) — Repurchase Of Capital Stock: -19195000.00
PLTR.TO income_statement (quarterly, 2025-09-30) — Research And Development: 144191000.00
PLTR.TO balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -4171066000.00
PLTR.TO cash_flow (quarterly, 2025-09-30) — Sale Of Investment: 3707565000.00
PLTR.TO income_statement (quarterly, 2025-09-30) — Selling And Marketing Expense: 274636000.00
PLTR.TO income_statement (quarterly, 2025-09-30) — Selling General And Administration: 436338000.00
PLTR.TO balance_sheet (quarterly, 2025-09-30) — Share Issued: 2383314028.00
PLTR.TO cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 172318000.00
PLTR.TO balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 6590457000.00
PLTR.TO balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 6590457000.00
PLTR.TO income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
PLTR.TO income_statement (quarterly, 2025-09-30) — Tax Provision: 3753000.00
PLTR.TO income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.01
PLTR.TO balance_sheet (quarterly, 2025-09-30) — Total Assets: 8113960000.00
PLTR.TO balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 6590457000.00
PLTR.TO balance_sheet (quarterly, 2025-09-30) — Total Debt: 235436000.00
PLTR.TO balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 6688269000.00
PLTR.TO income_statement (quarterly, 2025-09-30) — Total Expenses: 787836000.00
PLTR.TO balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 1425691000.00
PLTR.TO balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 527804000.00
PLTR.TO balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 245288000.00
PLTR.TO income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: 393256000.00
PLTR.TO cash_flow (quarterly, 2025-09-30) — Unrealized Gain Loss On Investment Securities: 5457000.00
PLTR.TO balance_sheet (quarterly, 2025-09-30) — Working Capital: 6405753000.00
PLTR.TO income_statement (annual, 2025-12-31) — +Operating Expense: 2272254000.00
PLTR.TO income_statement (quarterly, 2025-12-31) — +Operating Expense: 615442000.00
PLTR.TO income_statement (annual, 2025-12-31) — +Total Revenue: 4475446000.00
PLTR.TO income_statement (quarterly, 2025-12-31) — +Total Revenue: 1406802000.00
PLTR.TO balance_sheet (annual, 2025-12-31) — Accounts Payable: 8064000.00
PLTR.TO balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 8064000.00
PLTR.TO balance_sheet (annual, 2025-12-31) — Accounts Receivable: 1042065000.00
PLTR.TO balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 1042065000.00
PLTR.TO balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -149091000.00
PLTR.TO balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -149091000.00
PLTR.TO balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 10933325000.00
PLTR.TO balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 10933325000.00
PLTR.TO income_statement (annual, 2025-12-31) — Basic Average Shares: 43078387506.00
PLTR.TO income_statement (quarterly, 2025-12-31) — Basic Average Shares: 43392747611.00
PLTR.TO income_statement (annual, 2025-12-31) — Basic EPS: 0.04
PLTR.TO income_statement (quarterly, 2025-12-31) — Basic EPS: 0.01
PLTR.TO cash_flow (annual, 2025-12-31) — Beginning Cash Position: 2119936000.00
PLTR.TO cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 1644826000.00
PLTR.TO cash_flow (annual, 2025-12-31) — Capital Expenditure: -33882000.00
PLTR.TO cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -13272000.00
PLTR.TO balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 229338000.00
PLTR.TO balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 229338000.00
PLTR.TO balance_sheet (annual, 2025-12-31) — Capital Stock: 2391000.00
PLTR.TO balance_sheet (quarterly, 2025-12-31) — Capital Stock: 2391000.00
PLTR.TO balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 1423796000.00
PLTR.TO balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 1423796000.00
PLTR.TO balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 7177043000.00
PLTR.TO balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 7177043000.00
PLTR.TO cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: -26910000.00
PLTR.TO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -10898000.00